ABBVIE IRELAND UNLIMITED CO has a total of 153 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2006. It filed its patents most often in Australia, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are NAT INST OF BIOLOGICAL SCIENCES BEIJING, MOLECULAR INSIGHT PHARM INC and YAMANOUCHI PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 48 | |
#2 | EPO (European Patent Office) | 14 | |
#3 | Japan | 12 | |
#4 | Israel | 11 | |
#5 | Republic of Korea | 10 | |
#6 | Mexico | 8 | |
#7 | Ukraine | 5 | |
#8 | Canada | 4 | |
#9 | Chile | 4 | |
#10 | Hungary | 4 | |
#11 | Montenegro | 4 | |
#12 | China | 3 | |
#13 | EAPO (Eurasian Patent Organization) | 3 | |
#14 | Serbia | 3 | |
#15 | Costa Rica | 2 | |
#16 | Dominican Republic | 2 | |
#17 | Malaysia | 2 | |
#18 | New Zealand | 2 | |
#19 | Argentina | 1 | |
#20 | Brazil | 1 | |
#21 | Lithuania | 1 | |
#22 | Netherlands | 1 | |
#23 | Norway | 1 | |
#24 | Peru | 1 | |
#25 | Philippines | 1 | |
#26 | Singapore | 1 | |
#27 | Slovenia | 1 | |
#28 | Taiwan | 1 | |
#29 | Uruguay | 1 | |
#30 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Chemical engineering | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Elmore Steven | 28 |
#2 | Gao Yi | 27 |
#3 | Motter Christopher E | 23 |
#4 | Degoey David A | 23 |
#5 | Betebenner David A | 23 |
#6 | Liu Dachun | 23 |
#7 | Sarris Kathy | 23 |
#8 | Kati Warren M | 23 |
#9 | Pratt John K | 22 |
#10 | Song Xiaohong | 22 |
Publication | Filing date | Title |
---|---|---|
AU2016238925A1 | Anti-viral compounds | |
AU2015201698A1 | Process for preparing antiviral compounds | |
AU2015100283A4 | Methods for treating HCV | |
AU2015201117A1 | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
AU2015201020A1 | Methods for treating HCV | |
AU2015200715A1 | Methods for treating HCV | |
AU2014280934A1 | Phosphine ligands for catalytic reactions | |
AU2014200725A1 | Solid compositions | |
AU2013201585A1 | Methods for treating HCV | |
AU2013201758A1 | Methods for treating HCV | |
AU2012203474A1 | Anti-Viral Compounds | |
AU2012201327A1 | Macrocyclic hepatitis C serine protease inhibitors | |
MX2013009763A | Anti-viral compounds. | |
AU2012200399A1 | 1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors | |
TW201412707A | Anti-viral compounds | |
AU2011278926A1 | Phosphine ligands for catalytic reactions | |
KR20170037683A | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |